Cargando…
Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb(®))—A case report
Rhabdomyolysis (RM) is a potentially life‐threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb(®)) might increase its efficacy.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777160/ https://www.ncbi.nlm.nih.gov/pubmed/35079387 http://dx.doi.org/10.1002/ccr3.5272 |